Aram Ghalali

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Subarachnoid Hemorrhage

Heat Shock Protein

Top Venues

Cellular and molecular neurobiology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Sesen, Aram Ghalali, Jessica Driscoll, Tyra Martinez, Adrien Lupieri, David Zurakowski, Sanda Alexandrescu, Edward R Smith, Katie Pricola Fehnel
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology. Cellular and molecular neurobiology 44 (1) (2023)
Julie Sesen, Aram Ghalali, Jessica Driscoll, Tyra Martinez, Adrien Lupieri, David Zurakowski, Sanda Alexandrescu, Edward R Smith, Katie Pricola Fehnel
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology. Cellular and molecular neurobiology 44 (1) (2023)
Julie Sesen, Aram Ghalali, Jessica Driscoll, Tyra Martinez, Adrien Lupieri, David Zurakowski, Sanda Alexandrescu, Edward R Smith, Katie Pricola Fehnel
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology. Cellular and molecular neurobiology 44 (1) (2023)
Kun Zhou, Jae Eun Cheong, Subrahmanian Tarakkad Krishnaji, Aram Ghalali, Haojie Fu, Lufei Sui, Catherine Alix-Panabières, Laure Cayrefourcq, Diane Bielenberg, Lijun Sun, Bruce R Zetter
Inhibition of Wnt signaling in colon cancer cells via an oral drug that facilitates TNIK degradation. Molecular cancer therapeutics (2022)